SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)

A Poveda1, V Martinez2, C Serrano3

  • 1Department of Medical Oncology, Instituto Valenciano de Oncología, IVO, Valencia, Spain.

Insights

Gastrointestinal stromal tumors (GISTs) are common digestive tract cancers. Targeted therapies, like tyrosine kinase inhibitors, have significantly improved survival for GIST patients, especially when managed in specialized centers.

Area of Science:

  • Gastrointestinal stromal tumors (GISTs) research.
  • Oncology and targeted therapy development.

Background:

  • GISTs are the most frequent mesenchymal neoplasms in the digestive tract.
  • GISTs serve as a model for targeted therapy development.
  • Tyrosine kinase inhibitors (KIT/PDGFRA) have improved GIST survival.

Purpose of the Study:

  • To present the Spanish Society of Medical Oncology (SEOM) guidelines for GIST diagnosis and treatment.
  • To provide an updated consensus on managing GIST patients.

Main Methods:

  • Consensus development based on current evidence.
  • Multidisciplinary team approach recommendations.

Main Results:

  • Guidelines offer a consensus for GIST diagnosis and treatment.
  • Emphasis on multidisciplinary management in reference centers.

Conclusions:

  • SEOM guidelines provide a framework for optimal GIST patient care.
  • Multidisciplinary teams in reference centers are crucial for effective GIST management.